基于血常规及相关指数对NCP早期鉴别诊断的初步探讨
The Value of Blood Routine and Related Indexes for Early Differential Diagnosis in Novel Coronavirus Pneumonia: A Preliminary Study
DOI: 10.12677/HANSPrePrints.2020.51002, PDF, 下载: 718  浏览: 1,445 
作者: 周婷婷, 武凡祺, 王 虹, 万毅新:兰州大学第二医院呼吸内科,甘肃 兰州;魏丰贤:兰州大学第二临床医学院,甘肃 兰州;刘 钊:兰州大学第一医院放射科,甘肃 兰州
关键词: 新型冠状病毒肺炎血常规早期诊断鉴别诊断New Coronavirus Pneumonia Blood Routine Early Diagnosis Differential Diagnosis
摘要: 目的:探讨血常规及相关指数在新型冠状病毒肺炎(NCP)早期鉴别诊断中的价值。方法:回顾性分析2020年1月23日至2020年2月10日兰州大学第二医院确诊的5例NCP患者、11例疑似病例及同期住院的12例其他肺炎患者的血常规、中性粒细胞/淋巴细胞比值(NLR)、血小板/淋巴细胞比值(PLR)和淋巴细胞/单核细胞比值(LMR)的差异,运用受试者工作特征(ROC)曲线的曲线下面积(AUC)评价其对NCP早期鉴别诊断的价值。结果:与疑似病例和其他肺炎患者相比,NCP患者早期WBC、BA#和PLT均降低,存在显著性差异(P < 0.05)。ROC分析显示,WBC对应AUC为0.95 (95% CI = 0.87~1.03),BA#对应AUC为0.86 (95% CI = 0.70~1.01),PLT对应AUC为0.85 (95% CI = 0.64~1.07)。结论:基于有限的临床病例,血常规中WBC、BA#和PLT下降均对NCP患者的早期鉴别诊断具有参考价值,但此结论仍需大样本研究进一步证实。
Abstract: Objective: To explore the value of blood routine and related indexes in the early differential diag-nosis of new coronavirus pneumonia (NCP). Methods: A retrospective analysis of hospitalized pa-tients diagnosed as NCP (n = 5), suspected (n = 11 ) and other pneumonia (n = 12) during January 23, 2020 to February 10, 2020 were conducted. The data in blood routine test at initial visit as well as calculated neutrophil/ lymphocyte ratio (NLR), platelet/ lymphocyte ratio (PLR), and lympho-cyte/monocyte ratio (LMR) were collected and compared. And the receiver operating characteristic (ROC) curve was used to evaluate the area under the curve (AUC) for early differential diagnosis of NCP. Results: Compared with suspected cases and other pneumonia patients, early NCP patients were associated with significantly reduced counts of WBC, BA# and PLT (P <0.05). ROC analysis showed that the AUC of WBC was 0.95 (95%CI, 0.87 to 1.03), AUC of BA# was 0.86 (95%CI, 0.70 to 1.01), and AUC of PLT was 0.85 (95%CI, 0.64 to 1.07). Conclusions: Based on limited number of cases, all of the reduction of WBC, BA# and PLT in blood routine is valuable for the early differential diagnosis of NCP patients, while the finding needs to be further confirmed by large sample studies.
文章引用:周婷婷, 魏丰贤, 刘钊, 武凡祺, 王虹, 万毅新. 基于血常规及相关指数对NCP早期鉴别诊断的初步探讨[J]. 汉斯预印本, 2020, 5(1): 1-8. https://doi.org/10.12677/HANSPrePrints.2020.51002

参考文献

[1] 国家卫健委. 新型冠状病毒感染的肺炎诊疗方案(试行第五版)[J/OL].中国中西医结合杂志, 2020: 1-3. http://kns.cnki.net/kcms/detail/11.2787.R.20200208.1034.002.html.
[2] Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. New England Journal of Medicine, 2020. DOI: 10.1056/NEJMoa2001017.
[3] Hui D S, I Azhar E, Madani T A, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China[J]. International Journal of Infectious Diseases, 2020, 91: 264-266.
[4] Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia[J]. New England Journal of Medicine, 2020. DOI: 10.1056/NEJMoa2001316
[5] Wei-jie Guan, Zheng-yi Ni, Yu Hu, et al. Clinical characteristics of 2019 novel coro-navirus infection in China [J]. medRxiv, 2020: 20020974. DOI: 10.1101/2020.02.06.20020974.
[6] Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. The Lancet, 2020, 395: 507-513.
[7] Jin, Y., Cai, L., Cheng, Z. et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Med Res, 2020, 7: 4. DOI: 10.1186/s40779-020-0233-6.
[8] 潘颖, 管世鹤, 杨凯, et al. 外周血血小板/淋巴细胞比值在非小细胞肺癌诊断中的价值 [J]. 细胞与分子免疫学杂志, 2016(12):1683-1686.
[9] 叶涛,杨银,王凯,等.中性粒细胞/淋巴细胞比率预测慢性阻塞性肺疾病患者并发2型糖尿病的价值:前瞻性队列研究[J]. 南方医科大学学报, 2017(10): 1308-1314.
[10] 魏丰贤, 倪彬, 蔡润津, 等. 肝硬化门静脉高压患者断流术后血小板形态及其相关指数的回顾性分析[J]. 第十届全国疑难及重症肝病大会论文汇编, 2019: 176, ID 055.
[11] 姚璜,杨盛力,魏守蓉.新形势下应对新型冠状病毒,防控为首[J/OL].医药导报, 2020: 1-9. http://kns.cnki.net/kcms/detail/42.1293.R.20200211.2022.005.html.
[12] 李舍予,黄文治,廖雪莲,等.新型冠状病毒感染医院内防控的华西紧急推荐[J/OL].中国循证医学杂志, 2020: 1-9. [2020-02-15]. http://kns.cnki.net/kcms/detail/51.1656.r.20200204.1640.004.html.
[13] 钟飞扬,张寒菲,王彬宸,等.新型冠状病毒肺炎的CT影像学表现[J/OL].武汉大学学报(医学版), 2020: 1-5. https://doi.org/10.14188/j.1671-8852.2020.0061.
[14] 高璐,张静平,杜永浩,等.输入性新型冠状病毒肺炎的CT表现[J/OL].西安交通大学学报(医学版), 2020: 1-9. http://kns.cnki.net/kcms/detail/61.1399.r.20200213.1259.009.html.
[15] 徐旭,张莹,李新,李晓霞.各地区中医药预防新型冠状病毒(COVID-19)肺炎方案分析[J/OL].中草药, 2020: 1-7. http://kns.cnki.net/kcms/detail/12.1108.R.20200214.1506.002.html.